MedTrace Logo

Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness

NCT02180841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-08-21

No results posted yet for this study

Summary

The purpose of the proposed pilot study is to evaluate the effects of a soy protein isolate with naturally occurring isoflavones on the properties of HDL-C (total HDL-C, HDL particle size and HDL function), central blood pressure, and indices of arterial stiffness.

Conditions

Interventions

DIETARY_SUPPLEMENT

Soy Protein Powder (25g/d)

Participants will consume 25g soy protein powder daily for a 6 week treatment period.

DIETARY_SUPPLEMENT

Placebo

Participants will consume a placebo control powder containing 0g soy protein powder daily for a 6 week treatment period.

DIETARY_SUPPLEMENT

Soy Protein Powder (50g/d)

Participants will consume 50g soy protein powder daily for a 6 week treatment period.

Sponsors & Collaborators

  • DuPont Nutrition and Health

    collaborator INDUSTRY

  • Penn State University

    lead OTHER

Principal Investigators

  • Penny M Kris-Etherton, PhD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180841 on ClinicalTrials.gov